Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$23.08
0.381.67%
At close: -
$23.08
0.000.00%
After Hours: May 16, 4:00 PM EDT
Comments
Loading...
Tandem Diabetes Care Analyst Ratings and Price Targets | NASDAQ:TNDM | Benzinga
Tandem Diabetes Care Inc has a consensus price target of $41.96 based on the ratings of 27 analysts. The high is $82 issued by Wells Fargo on August 4, 2022. The low is $20 issued by Wells Fargo on May 1, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Stifel, and Wells Fargo on May 1, 2025, respectively. With an average price target of $36.67 between Canaccord Genuity, Stifel, and Wells Fargo, there's an implied 58.87% upside for Tandem Diabetes Care Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Stifel
Wells Fargo
Piper Sandler
Baird
1calculated from analyst ratings
Analyst Ratings for Tandem Diabetes Care
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/01/2025 | Buy Now | 155.63% | Canaccord Genuity | William Plovanic59% | $58 → $59 | Maintains | Buy | Get Alert |
| 05/01/2025 | Buy Now | 34.32% | Stifel | Mathew Blackman62% | $60 → $31 | Maintains | Buy | Get Alert |
| 05/01/2025 | Buy Now | -13.34% | Wells Fargo | Larry Biegelsen67% | $22 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/01/2025 | Buy Now | 29.98% | Piper Sandler | Matt O'Brien52% | $36 → $30 | Maintains | Overweight | Get Alert |
| 05/01/2025 | Buy Now | 3.99% | Baird | Jeff Johnson77% | $33 → $24 | Maintains | Neutral | Get Alert |
| 04/10/2025 | Buy Now | -13.34% | Mizuho | Anthony Petrone63% | → $20 | Initiates | → Neutral | Get Alert |
| 03/05/2025 | Buy Now | -4.68% | Morgan Stanley | Patrick Wood51% | $45 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/04/2025 | Buy Now | 3.99% | Citigroup | Joanne Wuensch75% | $35 → $24 | Downgrade | Buy → Neutral | Get Alert |
| 03/03/2025 | Buy Now | 3.99% | Goldman Sachs | David Roman42% | $42 → $24 | Maintains | Neutral | Get Alert |
| 03/03/2025 | Buy Now | -4.68% | Wells Fargo | Larry Biegelsen67% | $38 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/28/2025 | Buy Now | 129.64% | Barclays | Matt Miksic66% | $60 → $53 | Maintains | Overweight | Get Alert |
| 02/27/2025 | Buy Now | 138.3% | RBC Capital | Shagun Singh57% | $65 → $55 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | 42.98% | Baird | Jeff Johnson77% | $37 → $33 | Maintains | Neutral | Get Alert |
| 02/26/2025 | Buy Now | 172.96% | Canaccord Genuity | William Plovanic59% | $63 → $63 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 116.64% | Citigroup | Joanne Wuensch75% | $57 → $50 | Maintains | Buy | Get Alert |
| 12/02/2024 | Buy Now | 94.97% | Morgan Stanley | Patrick Wood51% | $45 → $45 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/08/2024 | Buy Now | 159.97% | Barclays | Matt Miksic66% | $58 → $60 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | 142.63% | Canaccord Genuity | William Plovanic59% | $57 → $56 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 60.31% | Baird | Jeff Johnson77% | $39 → $37 | Maintains | Neutral | Get Alert |
| 11/06/2024 | Buy Now | 81.98% | Bernstein | Lee Hambright69% | → $42 | Initiates | → Outperform | Get Alert |
| 10/04/2024 | Buy Now | 99.31% | Goldman Sachs | David Roman42% | → $46 | Initiates | → Neutral | Get Alert |
| 10/02/2024 | Buy Now | 181.63% | RBC Capital | Shagun Singh57% | → $65 | Initiates | → Outperform | Get Alert |
| 09/23/2024 | Buy Now | 94.97% | Morgan Stanley | Patrick Wood51% | $45 → $45 | Maintains | Equal-Weight | Get Alert |
| 08/22/2024 | Buy Now | 94.97% | Morgan Stanley | Patrick Wood51% | → $45 | Initiates | → Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | 146.97% | Canaccord Genuity | William Plovanic59% | → $57 | Initiates | → Buy | Get Alert |
| 08/05/2024 | Buy Now | 151.3% | Barclays | Matt Miksic66% | $55 → $58 | Maintains | Overweight | Get Alert |
| 08/02/2024 | Buy Now | 138.3% | Wells Fargo | Larry Biegelsen67% | $50 → $55 | Maintains | Overweight | Get Alert |
| 08/02/2024 | Buy Now | 68.98% | Baird | Jeff Johnson77% | $36 → $39 | Maintains | Neutral | Get Alert |
| 08/02/2024 | Buy Now | 138.3% | Piper Sandler | Matt O'Brien52% | $50 → $55 | Reiterates | Overweight → Overweight | Get Alert |
| 06/10/2024 | Buy Now | 151.3% | Oppenheimer | Steven Lichtman62% | $47 → $58 | Maintains | Outperform | Get Alert |
| 05/30/2024 | Buy Now | 159.97% | Redburn Atlantic | Issie Kirby31% | → $60 | Initiates | → Buy | Get Alert |
| 05/29/2024 | Buy Now | 159.97% | Stifel | Mathew Blackman62% | $55 → $60 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | 224.96% | Lake Street | Brooks O'Neil35% | $60 → $75 | Maintains | Buy | Get Alert |
| 05/22/2024 | Buy Now | 146.97% | Citigroup | Joanne Wuensch75% | $40 → $57 | Upgrade | Neutral → Buy | Get Alert |
| 05/22/2024 | Buy Now | 138.3% | Stifel | Mathew Blackman62% | $45 → $55 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 138.3% | Barclays | Matt Miksic66% | $39 → $55 | Maintains | Overweight | Get Alert |
| 05/03/2024 | Buy Now | 94.97% | Stifel | Mathew Blackman62% | $40 → $45 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 116.64% | Wells Fargo | Larry Biegelsen67% | $45 → $50 | Maintains | Overweight | Get Alert |
| 05/03/2024 | Buy Now | 116.64% | Piper Sandler | Matt O'Brien52% | $35 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | Buy Now | 55.98% | Baird | Jeff Johnson77% | $28 → $36 | Maintains | Neutral | Get Alert |
| 04/29/2024 | Buy Now | 94.97% | Wells Fargo | Larry Biegelsen67% | $21 → $45 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/25/2024 | Buy Now | 94.97% | Leerink Partners | Mike Kratky65% | $34 → $45 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/23/2024 | Buy Now | 73.31% | Stifel | Mathew Blackman62% | $37 → $40 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 64.64% | Citigroup | Joanne Wuensch75% | $31 → $38 | Maintains | Neutral | Get Alert |
| 03/26/2024 | Buy Now | 60.31% | Stifel | Mathew Blackman62% | $24 → $37 | Upgrade | Hold → Buy | Get Alert |
| 03/15/2024 | Buy Now | 34.32% | Citigroup | Joanne Wuensch75% | $25 → $31 | Maintains | Neutral | Get Alert |
| 02/05/2024 | Buy Now | 3.99% | Stifel | Rick Wise73% | $17 → $24 | Maintains | Hold | Get Alert |
| 11/02/2023 | Buy Now | 8.32% | Piper Sandler | Matt O'Brien52% | $40 → $25 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -9.01% | Leerink Partners | Mike Kratky65% | → $21 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | -0.35% | Citigroup | Joanne Wuensch75% | $31 → $23 | Maintains | Neutral | Get Alert |
| 10/02/2023 | Buy Now | 94.97% | Jefferies | Matthew Taylor69% | $47 → $45 | Maintains | Buy | Get Alert |
| 08/21/2023 | Buy Now | 34.32% | Citigroup | Joanne Wuensch75% | $33 → $31 | Maintains | Neutral | Get Alert |
| 08/21/2023 | Buy Now | 38.65% | Baird | Jeff Johnson77% | $33 → $32 | Maintains | Neutral | Get Alert |
| 08/07/2023 | Buy Now | 168.63% | Barclays | Matt Miksic66% | $71 → $62 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | 47.31% | TD Cowen | Joshua Jennings55% | $52 → $34 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | 29.98% | Wells Fargo | Larry Biegelsen67% | $40 → $30 | Maintains | Equal-Weight | Get Alert |
| 08/04/2023 | Buy Now | 42.98% | Baird | Jeff Johnson77% | $38 → $33 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 42.98% | Citigroup | Joanne Wuensch75% | $45 → $33 | Downgrade | Buy → Neutral | Get Alert |
| 06/13/2023 | Buy Now | 116.64% | Craig-Hallum | Alexander Nowak52% | $74 → $50 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 94.97% | Citigroup | Joanne Wuensch75% | $55 → $45 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | 42.98% | B of A Securities | Travis Steed58% | $45 → $33 | Downgrade | Neutral → Underperform | Get Alert |
| 05/04/2023 | Buy Now | 73.31% | Wells Fargo | Larry Biegelsen67% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/04/2023 | Buy Now | 64.64% | Baird | Jeff Johnson77% | $40 → $38 | Maintains | Neutral | Get Alert |
| 04/24/2023 | Buy Now | — | Raymond James | Jayson Bedford68% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/29/2023 | Buy Now | 94.97% | UBS | Danielle Antalffy60% | → $45 | Initiates | → Neutral | Get Alert |
| 02/24/2023 | Buy Now | 103.64% | Raymond James | Jayson Bedford68% | $52 → $47 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | 125.3% | Cowen & Co. | Joshua Jennings55% | $61 → $52 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | 73.31% | Baird | Jeff Johnson77% | $45 → $40 | Maintains | Neutral | Get Alert |
| 02/23/2023 | Buy Now | 116.64% | Piper Sandler | Matt O'Brien52% | $70 → $50 | Maintains | Overweight | Get Alert |
| 01/26/2023 | Buy Now | — | Wolfe Research | Mike Polark57% | — | Initiates | → Peer Perform | Get Alert |
| 11/15/2022 | Buy Now | 86.31% | Wells Fargo | Larry Biegelsen67% | → $43 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 125.3% | Raymond James | Jayson Bedford68% | $92 → $52 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 203.29% | Piper Sandler | Matt O'Brien52% | $80 → $70 | Maintains | Overweight | Get Alert |
| 10/18/2022 | Buy Now | 224.96% | Barclays | Matt Miksic66% | → $75 | Initiates | → Overweight | Get Alert |
| 10/12/2022 | Buy Now | 224.96% | Jefferies | Matthew Taylor69% | → $75 | Initiates | → Buy | Get Alert |
| 09/07/2022 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
| 08/09/2022 | Buy Now | 112.31% | Wells Fargo | Larry Biegelsen67% | $82 → $49 | Downgrade | Overweight → Underweight | Get Alert |
| 08/04/2022 | Buy Now | 289.95% | Raymond James | Jayson Bedford68% | $125 → $90 | Maintains | Outperform | Get Alert |
| 08/04/2022 | Buy Now | 255.29% | Wells Fargo | Lawrence Biegelsen47% | $166 → $82 | Maintains | Overweight | Get Alert |
| 08/04/2022 | Buy Now | 246.62% | Piper Sandler | Matt O'Brien52% | $120 → $80 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Tandem Diabetes Care (TNDM) stock?
The latest price target for Tandem Diabetes Care (NASDAQ:TNDM) was reported by Canaccord Genuity on May 1, 2025. The analyst firm set a price target for $59.00 expecting TNDM to rise to within 12 months (a possible 155.63% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tandem Diabetes Care (TNDM)?
The latest analyst rating for Tandem Diabetes Care (NASDAQ:TNDM) was provided by Canaccord Genuity, and Tandem Diabetes Care maintained their buy rating.
When was the last upgrade for Tandem Diabetes Care (TNDM)?
The last upgrade for Tandem Diabetes Care Inc happened on December 2, 2024 when Morgan Stanley raised their price target to $45. Morgan Stanley previously had an equal-weight for Tandem Diabetes Care Inc.
When was the last downgrade for Tandem Diabetes Care (TNDM)?
The last downgrade for Tandem Diabetes Care Inc happened on March 5, 2025 when Morgan Stanley changed their price target from $45 to $22 for Tandem Diabetes Care Inc.
When is the next analyst rating going to be posted or updated for Tandem Diabetes Care (TNDM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tandem Diabetes Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tandem Diabetes Care was filed on May 1, 2025 so you should expect the next rating to be made available sometime around May 1, 2026.
Is the Analyst Rating Tandem Diabetes Care (TNDM) correct?
While ratings are subjective and will change, the latest Tandem Diabetes Care (TNDM) rating was a maintained with a price target of $58.00 to $59.00. The current price Tandem Diabetes Care (TNDM) is trading at is $23.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
